Jordan Seth Rubin – Trademark Portfolio

Entity Type: 01

Jordan Seth Rubin holds 15 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 8 filings in this category. The portfolio also extends into Class 3 (Cosmetics & Cleaning) across 4 Nice Classification classes. Currently, 0 trademarks are registered and 3 are pending. The owner is based in College Grove, TN.

7317 Harlow Drive

College Grove, TN 37046

15 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Jordan Seth Rubin's trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (8 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

3
Cosmetics & Cleaning (6 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

32
Light Beverages (2 filings)

Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does Jordan Seth Rubin have?

Jordan Seth Rubin has 15 U.S. trademarks filed with the USPTO. Of these, 3 pending, 12 abandoned.

What trademark classes does Jordan Seth Rubin file in?

Jordan Seth Rubin files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 3 (Cosmetics & Cleaning), Class 32 (Light Beverages), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Jordan Seth Rubin's trademark registration success rate?

Jordan Seth Rubin has a 0% trademark registration rate, with 0 out of 12 resolved applications resulting in successful registration. Currently, 3 applications are pending review.